Intercourse Avoidance among Women with Coronary Artery Disease by Assari, Shervin
ORIGINAL RESEARCH—PSYCHOLOGY
Intercourse Avoidance among Women with Coronary
Artery Disease
Shervin Assari, MD, MPH*†
*Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, MI,
USA; †Center for Research on Ethnicity, Culture, and Health (CRECH), University of Michigan School of Public Health,
Ann Arbor, MI, USA
DOI: 10.1111/jsm.12459
A B S T R A C T
Introduction. Avoidance of sexual intercourse has not been frequently studied among patients with chronic medical
conditions and patients with coronary artery disease (CAD) are not exception.
Aim. We aimed to (i) compare intercourse avoidance during the past 2 weeks among women with CAD and healthy
controls; and (ii) to determine factors associated with intercourse avoidance during the past 2 weeks among women
with CAD.
Methods. This study was conducted in an outpatient cardiology clinic in Tehran, Iran. The study included 152
married women with CAD and 50 controls. Socio-demographic and clinical data including the severity of angina
(WHO Rose Questionnaire), risk factors (cigarette smoking, hyperlipidemia, diabetes, and obesity), fatigue, physical
function (visual analogue scale [VAS]) and somatic comorbidities [Ifudu index], symptoms of anxiety and depression
(Hospital Anxiety and Depression Scale [HADS]), and dyadic adjustment (Revised-Dyadic Adjustment Scale
[R-DAS]) were considered as independent variables. Logistic regression was used to determine predictors of sexual
avoidance during the past 2 weeks.
Main Outcome Measures. The main outcome was intercourse avoidance over a 2-week period, measured by the
Relation and Sexuality Scale (RSS).
Result. Avoidance of intercourse during the past 2 weeks was higher among women with CAD than controls (73.0%
vs. 56%, P = 0.024). According to the logistic regression, intercourse avoidance was positively associated with age
(Odds ratio [OR] = 1.127, 95% conﬁdence interval [CI] = 1.073, 1.185), somatic comorbidities (OR = 1.137, 95%
CI = 1.061, 1.218) and depressive symptoms (OR = 1.150, 95% CI = 1.022, 1.293).
Conclusion. Our study suggests that among women with CAD, age, depressive symptoms and somatic comorbidities
are associated with avoidance of intercourse. As having intercourse is safe among patients with stable CAD, all health
professionals should discuss sexual behaviors with their female CAD patients, especially those that are older, with
higher depressive symptoms or multiple comorbidities so as to allay fears about sexual functioning. Assari S.
Intercourse avoidance among women with coronary artery disease. J Sex Med 2014;11:1709–1716.
Key Words. Coronary Artery Disease; Heart Disease; Sexual Function; Sexual Intercourse; Avoidance of Sexual
Intercourse; Dyadic Adjustment; Psychological Status; Somatic Comorbidities
Introduction
Although intercourse is safe among patientswith coronary artery disease (CAD), a major
proportion of patients may avoid sexual inter-
course [1]. Intercourse avoidance is an indicator of
poor sexual function [2] and may reduce quality of
life [3]. Although people may also avoid sex for
reasons such as pain or body image [4,5], concerns
about possible health effects are also another
reason that make patients with chronic conditions
such as CAD avoid sex [6].
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Decreased sexual activity among cardiac
patients is frequently reported [7]. Concerns about
possible negative consequences of sexual activity
may lead to reduced sexual activity among patients
with CAD [8–10]. The American Heart Associa-
tion scientiﬁc statement regarding sexual activity
among patients with CAD has well addressed
safety and timing of return to sexual activity after
cardiac events [7]. Literature has shown that
patients with CAD can enjoy a sexually active life
[1]. The risk of experiencing any severe complica-
tion during sexual activity in these patients is far
less than that expected by patients and their part-
ners. Statistics show that sexual activity is a con-
tributor to myocardial infarction (MI) in less than
1% of the patients [11].
Although among patients with CAD comorbid
mental and somatic conditions contribute to a
reduced well-being [12–15], and sexual function is
an important indicator of well-being [16–18],
there is a dearth of information about possible
inﬂuence of anxiety, depression, and somatic
comorbidities on sexual activity among women
with CAD [19–21]. Historically, most of the litera-
ture on sexuality has focused on sexual dysfunction
rather than sexual activity. As a result, there is need
for studies on associated factors of sexual avoid-
ance among female patients with CAD.
This study sought to compare intercourse
avoidance between women with CAD and their
matched controls, and to determine factors asso-




This cross-sectional study was conducted in the
outpatient cardiology clinic of a tertiary hospital in
Tehran, Iran. The study was approved by the
in-house ethics committee of the hospital. Written
informed consent was obtained from all partici-
pants. Interviews were completed in a conﬁdential
setting, and the patients’ information was kept
conﬁdential.
One hundred and ﬁfty two patients with docu-
mented CAD and also 50 socio-demographically
—matched healthy controls were enrolled to this
study. This study deﬁned CAD as presence of ste-
nosis higher than 50% in at least one major coro-
nary artery on angiography. Participants were
selected from patients participating in outpatient
follow-up in the cardiology clinic. Inclusion crite-
ria consisted of being married for a minimum of
1 year, and not having a disabling psychiatric dis-
order. Having a history of MI or hospitalization
due to CAD during the past 6 months were among
the exclusion criteria.
A convenience sample of healthy control
females with no chronic conditions was selected
from subway stations and parks in Tehran. Age,
education level, income, and living place were not
signiﬁcantly different between the two groups
(P > 0.05 for all comparisons).
Measurements
Socio-demographic data (age, education level,
income, and living place) and clinical data (angina
grade, cigarette smoking, body mass index [BMI],
chronic obstructive pulmonary disease [COPD],
hypertension [HTN], cardiovascular accidents
[CVA], hyperlipidemia [HLP], and diabetes) as
well as symptoms of anxiety, symptoms of depres-
sion, somatic comorbidity, dyadic adjustment, and
fatigue and physical function (VAS) of all the
subjects were assessed. Participants ﬁlled out the
self-administered questionnaires after a trained




The World Health Organization (WHO)‘s angina
pectoris questionnaire was used for chest pain [18].
Angina pectoris was deﬁned based on the standard
criteria for chest pain or discomfort with the fol-
lowing characteristics: (i) the site must include
either the sternum (any level) or the left anterior
chest wall and the left arm; (ii) it must be provoked
by either hurrying or walking uphill or walking on
the level ground; (iii) if occurred while walking it
must make the subject either stop walking or
slacken his/her pace, unless nitrates are taken; and
(iv) it must disappear within 10 minutes from the
time upon which the subject stands still. Even in
the absence of one of these criteria, the subject is
not considered to have angina pectoris [22].
Anxiety and Depression Symptoms
The Hospital Anxiety and Depression Scale
(HADS), comprised of 14 statements relevant to
generalized anxiety (7 items) and depression (7
items) [23], was also employed. With a Cronbach’s
Alpha coefﬁcient equal to 0.78 for the HADS
anxiety sub-scale and 0.86 for the HADS depres-
sion sub-scale, the translated version of HADS is
routinely used in Iran [24–26]. In this test, four
possible answers with scores ranging from zero to
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three are provided for each question. The
maximum score for each scale is estimated to be
21. Based on the Zigmond and Snaith cut point,
scores greater than 8 are considered as abnormal
depression and anxiety symptoms [23].
Somatic Comorbidity
Somatic comorbidity was measured based on a
modiﬁed Ifudu Scale, a numerical scale devised
for the measurement of comorbidity in patients
undergoing hemodialysis. The 12-component
index is qualiﬁed for evaluating the function of 12
main systems in the human body: 1) non-ischemic
cardiovascular problems, 2) respiratory diseases, 3)
autonomic neuropathy, 4) other neurologic prob-
lems, 5) neuromuscular disorders, 6) infections
including AIDS, 7) liver, pancreases and biliary
diseases (hepatitis, hepatic disorder, and pancreatic
enzyme defect), 8) hematologic problems, 9) ver-
tebral column problems, lower back pain, or
arthritis, 10) visual disorders, 11) limb amputation
(from ﬁnger amputation up to lower extremity
amputation) and 12) genitourinary diseases. Scores
between 0 (absence of comorbidities) and 3 (pres-
ence of severe comorbidities) are dedicated to each
component. The total comorbidity score was cal-
culated by adding the scores gained in the above
mentioned items; all calculations were made by a
single internist, who sought consultation when
necessary. The scale ranged between 0–36, with a
higher score representing more comorbidity [27].
Although this measure is originally developed for
patients with chronic kidney disease, this measure
has been repeatedly used in a wide range of other
chronic conditions such as respiratory disease,
blood disease, and rheumatologic conditions, and
even ischemic heart disease [28–33].
Dyadic Adjustment
The Revised-Dyadic Adjustment Scale (R-DAS)
was utilized to assess the patients’ dyadic relation-
ships. The R-DAS consists of 14 items that evalu-
ated the agreement of a couple upon different
decisions, appropriate behavior, and dyadic satis-
faction and cohesion. The R-DAS scores range
from 0 to 69, with “distressed relation” having the
lowest score [34]. A Farsi version of the question-
naire was previously developed and validated in
Iran [35]. In the present study, the Cronbach’s
Alpha coefﬁcient for the questionnaire was 0.90.
Fatigue
Fatigue was measured using the Visual Analog
Scale (VAS). In this regard, a 100-mm line,
with one end (100) suggesting “no problem what
so ever” and the other end (0) anchored by
“unbearable”, was applied. The patients were then
instructed to place a vertical mark on the scale in
order to report their health status. A higher score
indicated a better health status [36].
Physical Dysfunction
Physical function was also measured using VAS,
with the higher score indicating a better status.
Main Outcome Measurement
Intercourse avoidance in the past 2 weeks was
determined using the Relation and Sexuality Scale
(RSS): The questionnaire asks respondents about
engagement in intercourse in the past 2 weeks.
Responses include never (0), once (1), twice (2),
three times (3), and four times or more (4). In this
study a response of none was considered as inter-
course avoidance. A Persian translation of RSS has
been utilized to measure sexual activity of male and
female patients with CAD [37–43]. Reliability of
this measure was .694 in our study. This scale score
is correlated with worse dyadic relationship, lower
quality of life, and higher anxiety, depression, and
somatic comorbidities (Appendix).
Statistical Analyses
The statistical analysis was carried out with SPSS
software for Windows version 13. Independent
sample t-tests were used to determine the associa-
tion between intercourse avoidance and age, BMI,
symptoms of anxiety, symptoms of depression,
somatic comorbidity and dyadic adjustment. The
association between nominal data such as educa-
tional level and intercourse avoidance, on the
other hand, was evaluated using a chi-square test.
A logistic regression model was applied to deter-
mine the predictors of intercourse avoidance. P
values lower than 0.05 were considered signiﬁcant.
Results
Comparison of Patients with CAD and Controls
Seventy percent of participants who were invited
to the study provided data on sexual behavior,
thus 152 patients with CAD and 50 healthy con-
trols enrolled in this analysis. The patients with
CAD and the healthy controls were not different
in terms of age (56.5 ± 9.1 vs. 53.8 ± 8.0, P = 0.08),
education level (16 [10.5%] vs. 10 [20%],
P = 0.083), living in urban areas (138 [90.8%] vs.
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45 [97.8%], P = 0.114), and income level lower
than 300 $US (15 [9.9%] vs. 9 [18%], P = 0.123).
Avoidance of Intercourse amongWomen with CAD
vs. Controls
Avoidance of intercourse during the past 2 weeks
was higher among women with CAD than among
women in the control group (111; 73.0% vs. 28;
56%, P = 0.024).
Patients with CAD
The mean age of the patients with CAD was
56.5 ± 9.1 years. Of these, 136 (89.5%) patients
had an education level lower than a high school
diploma, 137 (90.1%) had a monthly family
income lower than 300 $ US, and 138 (90.8%)
were city dwellers.
Frequencies of sexual intercourse over the past
2 weeks were once among 22.4%, twice among
2.6%, and more than twice among 2%. 111 (73%)
patients reported having no intercourse in the past
2 weeks.
Bivariate Analysis amongWomen with CAD
Women reporting intercourse avoidance were
older than those engaged in sexual intercourse
(mean age: 58.4 ± 8.7 vs. 51.3 ± 9.4, P < 0.001).
There was no signiﬁcant difference between the
educational status, family income, and living place
of the two groups.
Some 56 (50.5%) of the women reporting inter-
course avoidance and 12 (29.3%) of those who
were engaged in a sexual relation had a positive
history of CVA; the difference between the two
groups was signiﬁcant (P = 0.020). CAD was the
only clinical condition predicting ones engage-
ment in sexual relations, stressing that medical
conditions including COPD, HTN, HLP, diabe-
tes, BMI, cigarette smoking and the Rose Angina
Questionnaire have no effect on sexual avoidance.
The results of the bivariate analysis of symptoms
of anxiety, symptoms of depression, somatic
comorbidity, dyadic adjustment, fatigue and physi-
cal function in the two groups are presented in
Table 1.
Multivariate Analysis among Women with CAD
According to the logistic regression, the likelihood
of experiencing intercourse avoidance increased in
older ages (Odds ratio [OR] = 1.127, 95% conﬁ-
dence interval [CI] = 1.073, 1.185) and in those
with more somatic comorbidities (OR = 1.137,
95% CI = 1.061, 1.218) and higher depression
symptoms (OR = 1.150, 95% CI = 1.022, 1.293).
Discussion
Intercourse avoidance during a 2-week time inter-
val seems to be more common among women with
CAD than among the controls. Among women
with CAD, intercourse avoidance is more frequent
among patients who are older, and among patients
with higher depressive symptoms and somatic
comorbidities.
Although there are studies on intercourse
avoidance among patients with cancer [44],
psychiatric and psychosomatic disorders [45],
Alzheimer’s disease [46], traumatic brain injury
[47] and rheumatoid arthritis [48], there are not
many similar studies among female patients with
CAD. There are also reports on rates and predic-
tors of intercourse avoidance among healthy
[49,50] and pregnant [51] women. Several of these
studies support our ﬁndings about positive associa-
tion between age and intercourse avoidance
[44,49,50].
Instead of limiting the sample to patients
without diabetes mellitus, obesity, psychological
disorders, and sleep apnea, we measured com-
orbid conditions in the sample. This enabled us
to document an association between somatic
Table 1 Comparisons of anxiety, depression, somatic
comorbidity, marital adjustment, and quality of life
between patients who had and those who did not have




Mean ± SD* Mean ± SD*
HADS
Anxiety symptoms (0–18) 9.74 ± 5.89 7.82 ± 6.38 0.101
Depression symptoms
(0–24)
8.60 ± 3.45 6.51 ± 3.31 0.002†
Ifudu
Somatic comorbidity (0–42) 15.77 ± 6.76 12.76 ± 7.63 0.020†
R-DAS
Dyadic consensus (0–20) 16.38 ± 3.85 16.90 ± 3.95 0.464
Affectional expression
(0−10)
8.92 ± 2.54 9.05 ± 2.49 0.778
Dyadic satisfaction (0–20) 13.97 ± 5.72 16.34 ± 4.37 0.008†
Dyadic cohesion (0–19) 11.32 ± 5.07 12.71 ± 4.47 0.124
Total score (0–69) 50.59 ± 12.88 55.00 ± 12.67 0.062
VAS
Physical function (0–100) 33.90 ± 23.94 44.49 ± 27.09 0.023†
Fatigue (0–100) 49.59 ± 24.33 38.09 ± 24.20 0.010†
*Standard deviation.
†Significant.
HADS = hospital anxiety and depression score; R-DAS = revised-dyadic
adjustment scale; VAS = visual analog scale
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comorbidities (OR = 1.137) and depressive symp-
toms (OR = 1.150) and avoidance of sexual
intercourse.
Somatic comorbidities were considered to be an
important factor contributing to intercourse avoid-
ance. Previous studies have documented a strong
association between chronic conditions such as dia-
betes, stroke, rheumatoid and neurological condi-
tions on sexual function in general and frequency of
intercourse more speciﬁcally [52–54]. An earlier
investigation, however, failed to show an associa-
tion between somatic comorbidities and sexual fear
among patients with CAD [55].
In line with our study which showed an associa-
tion between higher somatic comorbidities and
intercourse avoidance, a recent review has shown
that intercourse, and not other sexual activities, is
associated with better physical and mental health
in both sexes [46]. Some previous studies have also
shown an association between frequency of inter-
course and some physical health measures includ-
ing heart rate variability and blood pressure
response to stress [56–58].
In our study among female patients with CAD,
symptoms of depression were positively associated
with intercourse avoidance. In one study, depres-
sion rather than anxiety was associated with fear of
sexual intercourse among patients with CAD [55].
Similarly, in patients with psychiatric and psycho-
somatic disorders, depressed individuals reported
fewer coital frequencies [45]. Another study on
middle-aged men reported depression as the main
contributor to sexual avoidance among patients
with myocardial infarction [59]. There are,
however, studies suggesting that depression and
other mental health factors may not play a major
role on sexual activity of patients [50,60].
Our bivariate analysis also showed that dyadic
satisfaction was lower among patients who had
avoided sexual intercourse. Higher frequency of
sexual intercourse with a partner may be associated
with better dyadic adjustment [50]. Poor dyadic
adjustment has been shown to be associated with
fear of sexual intercourse among patients with
CAD [55].
In line with previous studies [61], our bivariate
analysis suggested an association between fatigue
and physical function and frequency of sexual inter-
course among female patients with CAD. There
are, however, studies suggesting that fatigue and
physical function may have minimal effect on fre-
quency of intercourse in certain populations [38].
The study may have important clinical implica-
tions for cardiologists and other health care pro-
viders who have patients with CAD. Clinicians
should ask their female patients with CAD about
their speciﬁc concerns about sexual behaviors.
Possible concerns about negative health effects of
sex may contribute to impaired sexual function
among patients [6,8–10]. Physicians, nurses and
sex therapists who visit CAD patients should also
consider educating patients and their partners
about safety and timing of return to sexual activity
after cardiac events [1,7]. The American Heart
Association scientiﬁc statement can be consulted
in this regard [7]. Other possible reasons such as
pain, and body image that may hinder people from
a normal and active sexual life should also be dis-
cussed. In the case of stable CAD, patients should
be clearly and directly reassured that they can
enjoy an active sexual life [1]. Such a message
should be communicated directly and clearly to all
patients with CAD [11]. As sexual function is
essential for maintaining well-being [3], this
approach may enhance the quality of life of the
patients.
Limitations
Our study had several limitations. The study
abounds in medical nonsexual tools (WHO
Rose Questionnaire, VAS, Ifudu Index, HADS,
R-DAS), while the only speciﬁc sexual instrument
that was used is the RSS. Sexual dysfunctions—
which are major contributors of sexual behaviors
[62]—were not measured in this study. Sexual
desire among patients was not taken into consid-
eration, as well. Thus, although the current study
assessed several potential nonsexual clinical data
(angina grade, cigarette smoking, body mass
index, chronic obstructive pulmonary disease,
hypertension, cardiovascular accidents, hyper-
lipidemia, diabetes, anxiety, depression, somatic
comorbidities, dyadic adjustment, fatigue and
physical function) as possible predictors of inter-
course avoidance, the study is limited in covering
fundamental psycho-physiological elements of
sexuality (e.g., libido and sexual arousal). Libido
can potentially inﬂuence frequency of intercourse.
Through physiological sexual mechanisms, sexual
arousal (or contrary, sexual dysfunction) is known
to inﬂuence frequency of intercourse. Previous
studies have shown that female patients with CAD
may have distinct sexual dysfunction compared
with healthy controls [63,64]. Thus, future
research in this area should study possible effects
of sexual dysfunction and libido on frequency of
intercourse among patients with CAD.
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Using theWHOangina questionnaire instead of
angiographic ﬁndings as a possible predictor is also
another limitation. Results of the WHO Rose
angina questionnaire (used in this study) have been
shown to be correlated with angiographic ﬁndings
[65]. In addition, controls were conveniently
sampled, and this should be considered as another
shortcoming. This study also did not take the post
or peri-menopausal state, or HRT into account.
Thus, there were possible confounders such as
alteration of hormones that were not measured in
this study. It should be added that using different
cut points and time intervals while deﬁning sexual
avoidance may lead to various results. While previ-
ous studies have assessed the frequency of inter-
course in a 1-month period, certain investigations
have also evaluated the condition in a 2-week
period, similar to that used in our study [66–68].
Finally, the 2-week study period is a relatively short
time to make inferences about sexual behavior of
our samples.The study could beneﬁt fromabefore-
after design. Although avoidance from sexual inter-
course is not sexual dysfunction [68], it is an
indicator of poor sexual life satisfaction [69,70].
Intercourse frequency is positively associated with
sexual satisfaction [71]. Intercourse avoidance is
known as an indicator of disturbance in sexual life
[2]. One of the strengths of our study was that
several measures such as psychological symptoms,
somatic comorbidities, and dyadic relation were
included [72,73].
Conclusion
Our study suggests that women with CAD may
more frequently avoid intercourse compared with
their healthy matched controls. Intercourse avoid-
ance may be more common among female CAD
patients who are older, have high depressive symp-
toms and also somatic comorbidities. As literature
conﬁrms that intercourse is safe among patients
with stable CAD, patients should receive health
communication messages about the safety of
sexual activity among CAD patients. Physicians
and other health care providers should consider
ways that sexual health can be promoted to their
female patients with CAD, especially those who
are older, and those who have higher depressive
symptoms or multiple comorbidities. Further
research should test if such strategies allay
patients’ fear about sexual functioning.
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Appendix Relationship and sexuality scale [37]
1 Negative effect of disease on sexual life Not at all Slightly Rather much Much Very much
2 Effect of disease on sexual desire Increased No change Decreased All gone
3 Effect of treatment on sexual desire Increased No change Decreased All gone
4 Satisfaction with frequency of hugs and
kisses
Not at all Slightly Rather much Much Very much
5 Fear of sexual intercourse Never Rarely Sometimes Often Always
6 Perceived fear of partner for sexual
intercourse
Never Rarely Sometimes Often Always
7 Frequency of sexual intercourse relative to















9 Satisfaction with your intercourse Not at all Slightly Rather much Much Very much
10 Frequency of sexual intercourse in last 2
weeks
None Once Twice Three times Four or more
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